REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Nov 14, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how two different supportive programs can help women feel better after they have abdominal gynecological surgery, such as surgery to remove a suspicious mass in the ovaries or uterus. The goal is to see which program is more effective in improving recovery by reducing pain, anxiety, and sleep problems after surgery.
To be eligible for this study, participants must be women aged 18 or older who are scheduled for this type of surgery and can read and understand English. Participants will need to provide their consent to join and should be in generally good health, as indicated by a specific performance status. Throughout the trial, women will receive support through one of the programs being tested, and researchers will monitor their progress to determine how well these programs work. If you're interested in participating, it's important to know that those with certain severe mental health conditions may not be eligible to join.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- • Provision of signed and dated informed consent form
- • Participants age 18 years and older
- • Scheduled for an abdominal gynecological surgery (i.e., uterine, ovarian) to remove a mass that is suspected to be malignant
- • Have an Eastern Cooperative Oncology Group (ECOG) performance status of ≤1
- • Able to understand, read and write English (since the intervention is conducted in English)
- Exclusion Criteria:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- • Presence of a psychotic disorder, current suicidal ideation, or other unstable major psychiatric condition documented by diagnosis in the medical chart.
- • Unwillingness or inability to follow study procedures
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Charlotte, North Carolina, United States
Patients applied
Trial Officials
Stephanie J Sohl, PhD
Principal Investigator
Wake Forest Baptist Comprehensive Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials